TCT-274 Drug-eluting balloon in 001 bifurcated lesions: 1 year clinical and 7-months angiographic outcomes

Beatriz Vaquerizo,Helena Tizón,Eduard Fernandez-Nofrerias, DARLENE ESTRADA-YÁNEZ, SUÀREZ DE LEZO Javier, Imanol Oategui,Jose R. Rumoroso,Pedro Martin Lorenzo,Faustino Miranda-Guardiola,Marcelo Bettinotti,Antonio Serra

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2014）

引用 0|浏览5

暂无评分

摘要

In the DES era, the best strategy to treat 001 bifurcated lesions remains unanswered. This is the first prospective registry assessing the efficacy and safety of second generation of drug-eluting balloon (DEB) (EurocorGm), (3.0μg/m2 balloon surface area), in patients with 001 bifurcated lesions

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要